Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Non-Current Deferred Revenue (2020 - 2025)

Updated

Vistagen Therapeutics' Non-Current Deferred Revenue came in at $176,000 for fiscal Q3 2026 (quarter ended Dec 31, 2025), down 61.2% from $454,000 a year earlier and down 47.6% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Non-Current Deferred Revenue (2020 - 2025) Analysis & Trends

At the end of FY2025 (ended Mar 31, 2025), Vistagen Therapeutics' Non-Current Deferred Revenue was $391,000, down 85.4% from FY2024.

  • Non-Current Deferred Revenue carries a four-year compound annual growth rate of -37.1% (FY2021 to FY2025).
  • Going back by fiscal year, Non-Current Deferred Revenue was $2.67 million in FY2024 (+15.5%), $2.32 million in FY2023 (+48.6%), $1.56 million in FY2022 (-37.5%) and $2.49 million in FY2021.
  • The fiscal Q3 2026 figure represents the lowest quarterly Non-Current Deferred Revenue in data going back to fiscal Q2 2021.
  • Year-over-year, Non-Current Deferred Revenue has declined for seven consecutive quarters, with an average decline of 56.1% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Deferred Revenue over five years came in fiscal Q3 2023 (growth of 75.5%), and the weakest in fiscal Q4 2025 (a decline of 85.4%).
  • Business Quant data shows VTGN's Non-Current Deferred Revenue at $336,000 (Q2 2026), $221,000 (Q1 2026) and $391,000 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 176,000.00
Sep 30, 2025 336,000.00
Jun 30, 2025 221,000.00
Mar 31, 2025 391,000.00
Dec 31, 2024 454,000.00
Sep 30, 2024 730,000.00
Jun 30, 2024 1.09 Mn
Mar 31, 2024 2.67 Mn
Dec 31, 2023 1.90 Mn
Sep 30, 2023 1.78 Mn
Jun 30, 2023 2.14 Mn
Mar 31, 2023 2.32 Mn
Dec 31, 2022 2.49 Mn
Sep 30, 2022 2.67 Mn
Jun 30, 2022 1.25 Mn
Mar 31, 2022 1.56 Mn
Dec 31, 2021 1.42 Mn
Sep 30, 2021 1.78 Mn
Jun 30, 2021 2.14 Mn
Mar 31, 2021 2.49 Mn
API Access

Vistagen Therapeutics Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY